New cancer drug shows early promise in safety trial
NCT ID NCT05767060
Summary
This early-stage study tested a new drug called BAT7104 in people with advanced cancers who had run out of standard treatment options. The main goal was to check the drug's safety, see how the body processes it, and look for early signs that it might help shrink tumors. Researchers tested different doses in 86 patients to find the safest amount for future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Li Zhang
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.